Previous Posts
- This blog has moved
- Avandia Given Positive Reviews Due to $$$$$?
- The FDA and Drug Approval
- J&J Planned Profit from Risky, Unapproved Uses of ...
- What Are the Different Classes of Drug Recalls?
- What Is the Difference Between Class Action and Mu...
- First Lawsuit for Avandia Filed In Santa Clara Cou...
- Our Involvement in the Yaz®/Yasmin® Litigation
- What Is An FDA Black Box Warning?
- What Is a Drug Recall?
Archives
- April 2008
- May 2008
- May 2009
- June 2009
- July 2009
- August 2009
- September 2009
- October 2009
- November 2009
- December 2009
- January 2010
- February 2010
- March 2010
- April 2010
Click Here to View
Our Other Site
Wednesday, October 7, 2009
Yaz/Yasmin/Ocella MDL transferred to Southern District of Illinois
The Judicial Panel of Multidistrict Litigation assigned the Yasmin And Yaz MDL to Judge David R. Herndon of the Southern District of Illinois. The Yaz/Yasmin/Ocella MDL, docket number 2100 was created for the purposes of consolidating all federal Yaz/Yasmin lawsuits alleging personal injury and wrongful death. The cases are now under the heading IN RE: Yasmin and Yaz (Drospirenone) Marketing and Sales Practices and Products Liability Litigation.
The Judicial Panel found the Southern District of Illinois will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation. U.S. District Court Judge David R. Herndon will preside over these Yaz and Yasmin cases for coordinated or consolidated pretrial proceedings. All consolidated actions share factual questions relating to at least one of the drospirenone-containing oral contraceptives Yaz and Yasmin, which are manufactured by Bayer. Plaintiffs in the products liability actions challenge the safety of those oral contraceptives and bring claims for personal injuries or wrongful death stemming from use of the drugs.
Yaz and Yasmin, as well as the generic Ocella, have been associated with various serious side effects, including Blood Clots, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Stroke, Cerebrovascular Accidents (CVA), Heart Attack, Myocardial Infarction, Gallbladder Disease / Injury, Gallbladder Removal (cholecystectomy), Kidney Failure or Renal Failure, Pancreatitis and even Death.
The Judicial Panel found the Southern District of Illinois will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation. U.S. District Court Judge David R. Herndon will preside over these Yaz and Yasmin cases for coordinated or consolidated pretrial proceedings. All consolidated actions share factual questions relating to at least one of the drospirenone-containing oral contraceptives Yaz and Yasmin, which are manufactured by Bayer. Plaintiffs in the products liability actions challenge the safety of those oral contraceptives and bring claims for personal injuries or wrongful death stemming from use of the drugs.
Yaz and Yasmin, as well as the generic Ocella, have been associated with various serious side effects, including Blood Clots, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Stroke, Cerebrovascular Accidents (CVA), Heart Attack, Myocardial Infarction, Gallbladder Disease / Injury, Gallbladder Removal (cholecystectomy), Kidney Failure or Renal Failure, Pancreatitis and even Death.
posted by
Megan M. McBride
at
4:26 PM
Friday, August 7, 2009
Plaintiffs Petition for Creation of MDL in Yaz
Currently, 32 complaints have been filed in federal court against the manufacturers of Yaz. Plaintiffs have alleged physical injuries as a result of Yaz use such as deep vein thrombosis, pulmonary embolism, heart attack, stroke, kidney failure, seizures, gall bladder injuries, and death. The federal plaintiffs have filed suit in various federal forums and have recently petitioned the Northern District of Ohio for a consolidation of all of the suits for Multi-District Litigation (MDL).
An MDL is the consolidation of all similar federal cases for pre-trial purposes. An MDL can be established when there are extremely similar claims against the same defendants and all of the claims have similar issues that will be litigated. MDLs are very efficient especially in a discovery sense because documents generally will only have to be produced once for every plaintiff that is involved in the MDL. Plaintiffs requested that the MDL for Yaz be established in the Northern District of Ohio because there are currently 14 of the 32 federal suits filed in that district. Plaintiffs argue that the Northern District of Ohio is a centralized location and will be the most convenient location for an MDL, given that most of the cases filed are already in the Northern District of Ohio.
See the Petition for the creation of an MDL at:
http://www.jpml.uscourts.gov/_Mats/WinMATS%20Pleadings/2100/MDL%202100%20Pleading%201.pdf
An MDL is the consolidation of all similar federal cases for pre-trial purposes. An MDL can be established when there are extremely similar claims against the same defendants and all of the claims have similar issues that will be litigated. MDLs are very efficient especially in a discovery sense because documents generally will only have to be produced once for every plaintiff that is involved in the MDL. Plaintiffs requested that the MDL for Yaz be established in the Northern District of Ohio because there are currently 14 of the 32 federal suits filed in that district. Plaintiffs argue that the Northern District of Ohio is a centralized location and will be the most convenient location for an MDL, given that most of the cases filed are already in the Northern District of Ohio.
See the Petition for the creation of an MDL at:
http://www.jpml.uscourts.gov/_Mats/WinMATS%20Pleadings/2100/MDL%202100%20Pleading%201.pdf
Labels: discovery, Federal court, MDL, YAZ
posted by
Colleen
at
12:48 PM